US Patent 7964700 Inhibitors of Taspase1 protease activity
Patent 7964700 was granted and assigned to Dana-Farber Cancer Institute on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+463 characters)
Article
Patent abstract
A novel protease, Taspase1, is described. Taspase1 is involved in the cleavage of the myeloid/lymphoid or mixed-lineage leukemia (i.e., MLL) protein, which is required for proper HOX gene regulation. Diagnostic methods utilizing Taspase1 are provided, as well as inhibitors of Taspase1. Methods of using the inhibitors of Taspase1 are also described. For example an inhibitor of Taspase1 can be used to treat a cancer, e.g., leukemia, in a subject.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Emily H. Y. Cheng0
James J. D. Hsieh0
Stanley J. Korsmeyer0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07964700 Inhibitors of Taspase1 protease activity US Patent 7964700 Inhibitors of Taspase1 protease activity
Infobox
Patent Number
079647000
Patent Number
79647000
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
079647000
Date of Patent
June 21, 2011
0Patent Application Number
118513010
Date Filed
September 6, 2007
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07964700 Inhibitors of Taspase1 protease activity
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07964700
Date of patent
June 21, 2011
Patent application number
11851301
Date Filed
September 6, 2007
Patent primary examiner
Find more entities like US Patent 7964700 Inhibitors of Taspase1 protease activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
